Canada markets open in 1 hour 51 minutes

Protalix BioTherapeutics, Inc. (PLX)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.2000+0.0600 (+5.26%)
At close: 04:00PM EDT
1.1600 -0.04 (-3.33%)
Pre-Market: 07:11AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 87.98M
Enterprise Value 65.86M
Trailing P/E 15.00
Forward P/E 10.00
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.74
Price/Book (mrq)2.95
Enterprise Value/Revenue 1.10
Enterprise Value/EBITDA 6.03

Trading Information

Stock Price History

Beta (5Y Monthly) 0.90
52-Week Change 3-47.37%
S&P500 52-Week Change 328.04%
52 Week High 32.5100
52 Week Low 31.0300
50-Day Moving Average 31.2218
200-Day Moving Average 31.5247

Share Statistics

Avg Vol (3 month) 3425.59k
Avg Vol (10 day) 3541.56k
Shares Outstanding 573.32M
Implied Shares Outstanding 673.32M
Float 854.52M
% Held by Insiders 114.58%
% Held by Institutions 113.00%
Shares Short (Apr 30, 2024) 46.99M
Short Ratio (Apr 30, 2024) 418.21
Short % of Float (Apr 30, 2024) 49.97%
Short % of Shares Outstanding (Apr 30, 2024) 49.53%
Shares Short (prior month Mar 28, 2024) 46.46M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 20, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Dec 20, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 11.48%
Operating Margin (ttm)-129.56%

Management Effectiveness

Return on Assets (ttm)6.45%
Return on Equity (ttm)44.48%

Income Statement

Revenue (ttm)59.65M
Revenue Per Share (ttm)0.83
Quarterly Revenue Growth (yoy)-60.90%
Gross Profit (ttm)N/A
EBITDA 9.3M
Net Income Avi to Common (ttm)6.85M
Diluted EPS (ttm)0.0800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)48.49M
Total Cash Per Share (mrq)0.66
Total Debt (mrq)26.37M
Total Debt/Equity (mrq)88.54%
Current Ratio (mrq)1.38
Book Value Per Share (mrq)0.41

Cash Flow Statement

Operating Cash Flow (ttm)5.87M
Levered Free Cash Flow (ttm)5.05M